Application 220673
- Type
- ANDA
- Sponsor
- ASCENT PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLOMIPHENE CITRATE | CLOMIPHENE CITRATE | TABLET;ORAL | 50MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220673-001 | CLOMIPHENE CITRATE | CLOMIPHENE CITRATE | 50MG | TABLET / ORAL | AB | 2026-05-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220673-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A220673-001 | CLOMIPHENE CITRATE | 50MG | TABLET / ORAL | AB | 2026-05-15 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220673-001 | CLOMIPHENE CITRATE | 50MG | TABLET / ORAL | AB | 2026-05-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A220673-001 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220673-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clomiphene Citrate | CLOMIPHENE CITRTAE | Acetris Pharma Holdings, LLC | 76c7550a-d527-4925-b19f-d8b52d567474 | 2026-06-29 | Warnings, Adverse reactions | Clomiphene Citrate |
| Clomiphene citrate | CLOMIPHENE CITRATE | ANI Pharmaceuticals, Inc. | b56e04f0-490d-4f10-a0ed-31c288f4f4c5 | 2026-06-09 | Warnings, Adverse reactions | Clomiphene citrate CLOMIPHENE CITRATE |
| Clomiphene Citrate | CLOMIPHENE CITRATE | Accord Healthcare Inc. | 79f64995-7425-44c6-9f44-f7d20daeff65 | 2025-12-01 | Warnings, Adverse reactions | Clomiphene Citrate CLOMIPHENE CITRATE |
| Clomiphene Citrate | CLOMIPHENE CITRATE | Advagen Pharma Ltd | c7baae81-74ef-4e36-a454-15e9b0fea7e5 | 2025-11-04 | Warnings, Adverse reactions | Clomiphene Citrate CLOMIPHENE CITRATE |
| MiloPhene | CLOMIPHENE CITRATE | Burel Pharmaceuticals, LLC | b56131e5-efc7-43af-ac13-4a2ae918df4e | 2025-10-07 | Warnings, Adverse reactions | CLOMIPHENE CITRATE |
| Clomiphene Citrate | CLOMIPHENE CITRTAE | RISING PHARMA HOLDINGS, INC. | 086eace1-51db-4d48-976c-9d39ef5be745 | 2025-09-18 | Warnings, Adverse reactions | Clomiphene Citrate |
| Clomiphene Citrate | CLOMIPHENE CITRATE | Cosette Pharmaceuticals NC Laboratories, LLC | 72719958-7454-4c54-9bb4-f3054d0c5d82 | 2025-08-21 | Warnings, Adverse reactions | Clomiphene Citrate CLOMIPHENE CITRATE |
| Clomid | CLOMIPHENE CITRATE | Cosette Pharmaceuticals, Inc. | 2ca373c1-4dba-4126-8616-5c533d606fe5 | 2025-01-31 | Warnings, Adverse reactions | CLOMIPHENE CITRATE |
| Clomiphene Citrate | CLOMIPHENE CITRTAE | Appco Pharma LLC | 2d257ec2-827c-4bc2-8f17-cf24520c3cad | 2024-11-18 | Warnings, Adverse reactions | Clomiphene Citrate |
| CLOMID | CLOMIPHENE CITRATE | A-S Medication Solutions | f15e9918-6001-4150-bd54-1364a6febcb8 | 2023-05-31 | Warnings, Adverse reactions | CLOMIPHENE CITRATE |